Your browser doesn't support javascript.
loading
Targeting the 5T4 oncofetal glycoprotein with an antibody drug conjugate (A1mcMMAF) improves survival in patient-derived xenograft models of acute lymphoblastic leukemia.
McGinn, Owen J; Krishnan, Shekhar; Bourquin, Jean-Pierre; Sapra, Puja; Dempsey, Clare; Saha, Vaskar; Stern, Peter L.
  • McGinn OJ; Immunology, Division of Molecular & Clinical Cancer Sciences, University of Manchester, UK.
  • Krishnan S; Paediatric Oncology, Division of Molecular & Clinical Cancer Sciences, University of Manchester, UK.
  • Bourquin JP; Tata Translational Cancer Research Center, Tata Medical Center, Kolkata, India.
  • Sapra P; Division of Oncology & Children's Research Center, University Children's Hospital, University of Zurich, Switzerland.
  • Dempsey C; Pfizer Inc. Pearl River, NY10965-1299, USA.
  • Saha V; Paediatric Oncology, Division of Molecular & Clinical Cancer Sciences, University of Manchester, UK.
  • Stern PL; Paediatric Oncology, Division of Molecular & Clinical Cancer Sciences, University of Manchester, UK Peter.Stern@cruk.manchester.ac.uk vaskar.saha@tmckolkata.com.
Haematologica ; 102(6): 1075-1084, 2017 06.
Article en En | MEDLINE | ID: mdl-28341731

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras / Anticuerpos Monoclonales Humanizados / Antígenos de Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Año: 2017 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras / Anticuerpos Monoclonales Humanizados / Antígenos de Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Año: 2017 Tipo del documento: Article